75 research outputs found

    Põhja-Karjalast üleriikliku muutuseni

    Get PDF
    Põhja-Karjala projekt sai 1972. aastal Soomes alguse kui riiklik katse- ja näidisprogramm kardiovaskulaarsete haiguste (KVH) vältimiseks. Töötati välja ulatuslik ühiskonnal põhinev tegevusplaan, mis haaras tervishoiuteenuseid, mitteriiklikke organisatsioone (MRO), tööstust, meediat ja riiklikku poliitikat. Analüüs näitas, et elanikkonna riskitegurid muutusid 1970ndatel Põhja-Karjalas oluliselt. Esialgse projekti (1972–1977) ajal saadud kogemusi on kasutatud ulatuslikult Soome tervishoiuprogrammides ja alates 1980ndatest on Soome eri osades saadud analoogilisi positiivseid tulemusi. Nii on suremus südamekoronaartõppe aastatel 1970–1975 vähenenud Põhja-Karjalas 75% ja kogu Soomes 65%. Eesti Arst 2005; 84 (4): 271-27

    Interventiotutkimusten merkitys terveyden edistämisessä

    Get PDF

    KTL kehittämässä Bosnia-Herzegovinan liittovaltion Kansanterveyslaitosta

    Get PDF

    Genotypes with the apolipoprotein ε4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men

    Full text link
    Earlier we reported that allelic variation in the gene coding for apolipoprotein (apoE) is a significant predictor of variation in the risk of coronary heart disease (CHD) death in a longitudinal study of elderly Finnish men. Here we address the question: which of the apoE genotypes confers the risk information in these men, and whether such information persists after other CHD risk factors are considered? We followed two cohorts of elderly Finnish men aged 65 to 84 years, one in Eastern ( n = 281) and the other in the Southwestern ( n = 344) Finland for 5 years during which 26 (9.3%) of the men from the Eastern cohort and 40 (11.6%) of the men in the Southwestern cohort died from CHD. Baseline high density lipoprotein (HDL) cholesterol and (HDL cholesterol) 2 in the Eastern cohort and age, and total and HDL cholesterol and smoking status in the Southwestern cohort were significant predictors of CHD death ( P < 0.05). The apoE genotypes were significant predictors in the Southwestern cohort at P = 0.02 and in the Eastern cohort at P = 0.18. In multivariable models, information about apoE genotypes improved the prediction at P = 0.10 level of statistical significance in both cohorts. When genotypes were considered separately, the ε2/4 combined with the ε4/4 in the Eastern cohort (odds ratio = 7.69, 95% CI = 1.67-35.52) and the ε3/4 in the Southwestern cohort (odds ratio = 2.44, 95% CI = 1.16–5.10) had sigificanctly greater odds of CHD death compared to the common ε3/3 genotype. We conclude that apoE genotypes confer risk information about CHD death in two cohorts of elderly Finnish men in a longitudinal study, and this information persists after adjustment for other CHD risk factors. Because different genotypes were predictors in these two cohorts, we further conclude that the utility of a particular genotype as a predictor of CHD death in other populations may depend on the distribution of risk factor profiles at baseline, geographically defined environmental exposures, the CHD mortality history, and the evolutionary history of background genotypes in the population considered.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/47643/1/439_2005_Article_BF02281882.pd
    • …
    corecore